Want to see MGX full AI Analyst Report?
Metagenomi, Inc. (MGX) Ratios
Metagenomi, Inc. Ratios
MGX's free cash flow for Q2 2026 was $-19.64M. For the 2026 fiscal year, MGX's free cash flow was decreased by $-125.00K and operating cash flow was $-19.51M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.22 | 6.91 | 4.04 | 7.56 | 4.33 |
| Quick Ratio | 7.22 | 6.91 | 4.04 | 7.56 | 4.33 |
| Cash Ratio | 1.82 | 0.73 | 2.04 | 3.80 | 1.56 |
| Solvency Ratio | -1.32 | -0.81 | -0.43 | -0.09 | -0.12 |
| Operating Cash Flow Ratio | -3.88 | -2.92 | -1.33 | 0.61 | 0.96 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -26.67 | 0.00 | 0.00 |
| Net Current Asset Value | $ 103.03M | $ 168.22M | $ 128.60M | $ -122.02M | $ -65.62M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.18 | 0.14 | 0.13 | 0.04 | 0.34 |
| Debt-to-Equity Ratio | 0.26 | 0.19 | 0.22 | -0.25 | -1.50 |
| Debt-to-Capital Ratio | 0.20 | 0.16 | 0.18 | -0.33 | 2.99 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -13.35 |
| Financial Leverage Ratio | 1.39 | 1.38 | 1.70 | -5.57 | -4.36 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | -24.02 | -426.14 | -68.72 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -455.51 | -79.29 |
| Debt to Market Cap | 0.00 | 0.00 | 0.01 | 0.00 | 0.50 |
| Interest Debt Per Share | 1.09 | 1.22 | 1.29 | 0.50 | 8.30 |
| Net Debt to EBITDA | 0.01 | -0.24 | 1.24 | 4.23 | -0.46 |
| Profitability Margins | |||||
| Gross Profit Margin | 78.91% | 100.00% | -110.93% | 89.92% | -59.26% |
| EBIT Margin | -348.77% | -159.81% | -175.38% | -237.94% | -8699.59% |
| EBITDA Margin | -327.68% | -149.47% | -165.98% | -227.87% | -8540.33% |
| Operating Profit Margin | -380.85% | -170.00% | -175.38% | -259.53% | -9854.73% |
| Pretax Profit Margin | -348.77% | -159.81% | -134.57% | -238.51% | -8823.87% |
| Net Profit Margin | -348.54% | -149.26% | -152.50% | -253.45% | -8823.87% |
| Continuous Operations Profit Margin | -348.54% | -149.26% | -152.50% | -253.45% | -8823.87% |
| Net Income Per EBT | 99.93% | 93.40% | 113.33% | 106.26% | 100.00% |
| EBT Per EBIT | 91.58% | 94.00% | 76.73% | 91.90% | 89.54% |
| Return on Assets (ROA) | -39.74% | -24.05% | -18.71% | -10.52% | -15.10% |
| Return on Equity (ROE) | -55.40% | -33.24% | -31.72% | 58.57% | 65.89% |
| Return on Capital Employed (ROCE) | -48.45% | -30.94% | -26.52% | -12.20% | -20.50% |
| Return on Invested Capital (ROIC) | -46.99% | -28.35% | -26.22% | -12.15% | -20.38% |
| Return on Tangible Assets | -39.74% | -24.05% | -18.71% | -10.52% | -15.10% |
| Earnings Yield | -145.61% | -57.79% | -17.67% | -11.28% | -35.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 82.66 | 41.60 | 18.26 | 13.50 | 0.50 |
| Payables Turnover | 3.57 | 0.00 | 52.71 | 0.86 | 0.29 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.53 | 0.91 | 0.69 | 0.52 | 0.01 |
| Asset Turnover | 0.11 | 0.16 | 0.12 | 0.04 | 0.00 |
| Working Capital Turnover Ratio | 0.14 | 0.24 | 0.17 | 0.09 | 0.00 |
| Cash Conversion Cycle | -97.80 | 8.77 | 13.06 | -396.52 | -541.02 |
| Days of Sales Outstanding | 4.42 | 8.77 | 19.99 | 27.04 | 736.01 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 102.22 | 0.00 | 6.92 | 423.55 | 1277.03 |
| Operating Cycle | 4.42 | 8.77 | 19.99 | 27.04 | 736.01 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.39 | -2.91 | -2.44 | 0.79 | 4.09 |
| Free Cash Flow Per Share | -2.40 | -3.00 | -2.70 | 0.42 | 3.60 |
| Dividend Paid and CapEx Coverage Ratio | -154.86 | -35.03 | -9.31 | 2.13 | 8.36 |
| Capital Expenditure Coverage Ratio | -154.86 | -35.03 | -9.31 | 2.13 | 8.36 |
| Operating Cash Flow Coverage Ratio | -2.19 | -2.38 | -1.90 | 1.60 | 0.50 |
| Operating Cash Flow to Sales Ratio | -3.53 | -2.09 | -2.04 | 1.73 | 99.82 |
| Free Cash Flow Yield | -148.25% | -83.05% | -26.20% | 4.08% | 34.93% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.69 | -1.73 | -5.66 | -8.86 | -2.85 |
| Price-to-Sales (P/S) Ratio | 2.39 | 2.58 | 8.63 | 22.46 | 251.58 |
| Price-to-Book (P/B) Ratio | 0.38 | 0.58 | 1.80 | -5.19 | -1.88 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.67 | -1.20 | -3.82 | 24.53 | 2.86 |
| Price-to-Operating Cash Flow Ratio | -0.68 | -1.24 | -4.23 | 13.00 | 2.52 |
| Price-to-Earnings Growth (PEG) Ratio | -0.05 | -0.12 | -0.10 | 0.13 | 0.00 |
| Enterprise Value Multiple | -0.72 | -1.96 | -3.96 | -5.63 | -3.41 |
| Enterprise Value | 59.28M | 153.47M | 293.97M | 220.47M | 70.77M |
| EV to EBITDA | -0.72 | -1.96 | -3.96 | -5.63 | -3.41 |
| EV to Sales | 2.35 | 2.93 | 6.57 | 12.82 | 291.22 |
| EV to Free Cash Flow | -0.66 | -1.37 | -2.90 | 14.00 | 3.31 |
| EV to Operating Cash Flow | -0.67 | -1.41 | -3.22 | 7.42 | 2.92 |
| Tangible Book Value Per Share | 4.26 | 6.28 | 5.74 | -1.99 | -5.49 |
| Shareholders’ Equity Per Share | 4.26 | 6.28 | 5.74 | -1.99 | -5.49 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.07 | -0.13 | -0.06 | 0.00 |
| Revenue Per Share | 0.68 | 1.40 | 1.19 | 0.46 | 0.04 |
| Net Income Per Share | -2.36 | -2.09 | -1.82 | -1.16 | -3.62 |
| Tax Burden | 1.00 | 0.93 | 1.13 | 1.06 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.77 | 1.00 | 1.01 |
| Research & Development to Revenue | 3.75 | 2.09 | 2.11 | 2.51 | 59.58 |
| SG&A to Revenue | 1.06 | 0.61 | 0.64 | 1.09 | 39.97 |
| Stock-Based Compensation to Revenue | 0.47 | 0.31 | 0.15 | 0.11 | 1.54 |
| Income Quality | 1.01 | 1.40 | 1.34 | -0.68 | -1.13 |
Currency in USD
